FDA Inspection
Provepharm Inc.Provepharm Inc. – FDA Inspection, Apr 22, 2022
Record Details
This FDA Inspection record concerns Provepharm Inc., with an inspection on April 22, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Provepharm Inc.
- Inspection Date
- April 22, 2022
- Product Type
- Drugs
View Company Profile
ID · 6df5a52c-4165-41d1-a4f4-5897bb8b3773
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1177220
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Provepharm Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 5, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Provepharm Inc.
- FDA Inspection 1240960 - 2024-04-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.